​Naked Brand Group Limited Provides Corporate Update on Financial and Operational Results of Proposed Acquisition Target FOH Online Corp.

Spotlight News  |

Naked Brand Group Limited  (NAKD), a global leader in intimate apparel and swimwear, has provided a corporate update on the financial and operational results of its proposed acquisition target, FOH Online Corp. (“FOH”), the exclusive licensee of the Frederick’s of Hollywood global online license.

FOH net sales for the trailing twelve months ended June 30, 2018 were approximately $20.2 million of direct to consumer e-commerce sales, a 26% increase as compared to $16.0 million for the trailing twelve months ended June 30, 2017. Since 1946, Frederick's of Hollywood has set the standard for innovative apparel, introducing the push-up bra, the padded bra, and black lingerie to the U.S. The brand’s rich history has led it to become one of the most recognized in the world.

“We are pleased to see that FOH Online Corp.’s sales have grown at such a rapid rate in response to key improvements made over the last year,” stated Justin Davis-Rice, Chief Executive Officer of Naked Brand Group Limited. “This is a clear indication that FOH’s strategic pivot to their mobile platform with multiple enhancements is not only driving improved customer retention, but also new sales.

“We are in the final stages of negotiating the terms of our proposed acquisition of FOH Online Corp. Assuming we are able to finalize terms and enter into a definitive agreement with FOH Online Corp., we will seek to close the transaction in the third quarter of 2018 and believe the integration into our operations would provide a strong platform to drive the next phase of growth of our e-commerce business and provide opportunities for operating synergies with our extensive wholesale and retail distribution channels,” concluded Mr. Davis-Rice.

About the FOH Online Corp. Transaction

The Company is currently seeking to acquire all of the outstanding common stock of FOH in exchange for both shares of the Company and the forgiveness of debt owed by FOH to the Company’s wholly-owned subsidiary, Bendon Limited. If acquired, the Company would control FOH’s existing license to develop and sell online intimates products, sleepwear and loungewear products, swimwear and swimwear accessories and costumes products under the Fredrick’s of Hollywood name. While the Company has conducted advanced negotiations with FOH, the Company has not entered into a definitive agreement for the acquisition of FOH and there can be no assurance that the acquisition will occur. The proposed transaction is subject to negotiating the terms of, and executing, a definitive agreement relating to the proposed transaction and obtaining various third-party consents (which the Company and the shareholder of FOH are in the process of seeking to obtain). Furthermore, the terms of the transaction are still subject to discussion and may be changed as a result of any material positive or adverse change to the business of either party. Accordingly, there can be no assurance that a transaction will be entered into or that the proposed transaction will be consummated.

About Naked Brand Group Limited:

Naked Brand Group Limited is a leading intimate apparel and swimwear company with a diverse portfolio of brands. The company designs, manufactures and markets a portfolio of 11 company-owned and licensed brands, catering to a broad cross-section of consumers and market segments. Brands include Naked, Bendon, Bendon Man, Davenport, Fayreform, Hickory, Lovable, Pleasure State, Heidi Klum Intimates, Heidi Klum Man, Heidi Klum Swim. Naked Brand Group Limited products are available in 44 countries worldwide through 6,000 retail doors, a growing network of E-commerce sites and 61 company-owned Bendon retail and outlet stores in Australia and New Zealand. Brands are distributed through premier department stores, specialty stores, independent boutiques and third-party e-commerce sites globally, including Macy’s, Nordstrom, Saks Fifth Avenue, Harrods, Selfridges, Amazon and asos among others. For more information please visit www.nakedbrands.com.

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
NAKD Naked Brand Group Limited 3.64 -0.05 -1.27 115,087 Trade

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.